Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Nymox Pharmaceutical Corporation NYMX is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.20 million. The trailing-twelve-month return on investment at Meridian Bioscience, Inc. VIVO is 21.70%. Meridian Bioscience's EPS for the same period is $0.83. The trailing-twelve-month return on investment at IDEXX Laboratories, Inc. IDXX is 20.20%. IDEXX Laboratories' profit margin for the same period is 13.40%. The trailing-twelve-month return on investment at SurModics, Inc. SRDX is 11.20%. SurModics' PEG ratio is 1.66.